Aryannejad, Majid
Ghazi Oskouei, Hooman
Mazhari, Marzieh
Moradinezhad, Mehrnaz
Article History
Received: 12 February 2025
Accepted: 6 June 2025
First Online: 2 July 2025
Declarations
:
: After fully explaining the research process, patients or their parents signed the informed consent form. There were no costs for participation. The collected data are held confidential. The patients could leave the study at any stage, without their treatment being compromised. The study received ethics approval from the Ethical Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (IR.AJUMS.REC.1400.698). The study was prospectively registered with the Iranian Registry of Clinical Trials on March 28, 2022 (IRCT Code: IRCT20220315054292N1) before beginning the study. The protocol did not change after registration. All methods were performed in accordance with the relevant guidelines and regulations (including the Declaration of Helsinki); all experimental protocols were approved by the Institutional Review Board of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
: Not applicable.
: The authors declare no competing interests.